|
RASSF8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19609999999793E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.417380E-04 |
| Normal-vs-Stage2 |
1.882390E-03 |
| Normal-vs-Stage3 |
1.79717999999607E-05 |
| Normal-vs-Stage4 |
2.00209999999812E-05 |
| Stage1-vs-Stage2 |
9.100400E-01 |
| Stage1-vs-Stage3 |
1.792160E-01 |
| Stage1-vs-Stage4 |
2.020800E-01 |
| Stage2-vs-Stage3 |
2.972800E-01 |
| Stage2-vs-Stage4 |
2.493200E-01 |
| Stage3-vs-Stage4 |
8.016800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20729999999003E-05 |
| Normal-vs-AfricanAmerican |
1.752210E-02 |
| Normal-vs-Asian |
5.787900E-04 |
| Caucasian-vs-AfricanAmerican |
5.334600E-01 |
| Caucasian-vs-Asian |
6.137400E-01 |
| AfricanAmerican-vs-Asian |
8.224400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8344000000402E-06 |
| Normal-vs-Female |
1.387570E-04 |
| Male-vs-Female |
5.644300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.825100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.98574999999979E-05 |
| Normal-vs-Age(61-80Yrs) |
1.8396699999923E-05 |
| Normal-vs-Age(81-100Yrs) |
4.258300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.624820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.302570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.246400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.982400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.167600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.298200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.334430E-01 |
| Classical-VS-Follicular |
8.420000E-02 |
| Classical-VS-Other |
1.145820E-01 |
| Classical-VS-Normal |
4.757500E-04 |
| Tall-VS-Follicular |
7.257000E-01 |
| Tall-VS-Other |
3.602000E-01 |
| Tall-VS-Normal |
4.4735000000018E-05 |
| Follicular-VS-Other |
3.765600E-01 |
| Follicular-VS-Normal |
1.75677999999513E-05 |
| Other-VS-Normal |
1.165850E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77801999999838E-05 |
| Normal-vs-N1 |
7.69220000000903E-05 |
| N0-vs-N1 |
8.753200E-01 |
|
|
